Feb 4 (Reuters)- Wakamoto Pharmaceutical Co Ltd PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 7.31 5.81 10.00 (+25.9 pct) (+3.9 pct) (+28.4 pct) Operating 187 mln loss 341 mln 200 mln Recurring 222 mln loss 297 mln 250 mln Net 215 mln loss 19 mln 200 mln (+210.4 pct) EPS 6.19 yen loss 0.55 yen 5.76 yen Ann Div 3.00 yen 3.00 yen -Q2 div NIL NIL -Q4 div 3.00 yen 3.00 yen NOTE - Wakamoto Pharmaceutical Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T